|
YPEL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.281500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.424200E-02 |
| Normal-vs-Stage2 |
8.641900E-02 |
| Normal-vs-Stage3 |
6.218200E-01 |
| Normal-vs-Stage4 |
1.814040E-01 |
| Stage1-vs-Stage2 |
4.680000E-01 |
| Stage1-vs-Stage3 |
9.511700E-02 |
| Stage1-vs-Stage4 |
9.059700E-02 |
| Stage2-vs-Stage3 |
5.893800E-02 |
| Stage2-vs-Stage4 |
4.472200E-02 |
| Stage3-vs-Stage4 |
5.267400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.375000E-03 |
| Normal-vs-AfricanAmerican |
3.099200E-01 |
| Normal-vs-Asian |
8.610100E-02 |
| Caucasian-vs-AfricanAmerican |
1.643010E-01 |
| Caucasian-vs-Asian |
7.851900E-02 |
| AfricanAmerican-vs-Asian |
1.257560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.273650E-02 |
| Normal-vs-Female |
4.310300E-02 |
| Male-vs-Female |
8.426800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.351200E-01 |
| Normal-vs-Extreme_Weight |
1.391050E-01 |
| Normal-vs-Obese |
9.541600E-03 |
| Normal-vs-Extreme_Obese |
6.865000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.142600E-01 |
| Normal_Weight-vs-Obese |
4.350100E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.818400E-01 |
| Extreme_Weight-vs-Obese |
2.238400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.633200E-01 |
| Obese-vs-Extreme_Obese |
3.654000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.614980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.959030E-03 |
| Normal-vs-Age(61-80Yrs) |
6.598200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.408000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.565400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.271400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.767200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.605180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.455240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.925000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.25840000045841E-07 |
| Normal-VS-Type2 PRCC |
1.980290E-03 |
| Normal-VS-KIRP CIMP |
9.845000E-01 |
| Normal-VS-Unclassified PRCC |
8.618000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
<1E-12 |
| Type1 PRCC-VS-KIRP CIMP |
5.864600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.506370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.096200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.231300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.729760E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.611400E-01 |
| Normal-vs-N1 |
7.356400E-01 |
| Normal-vs-N2 |
2.744200E-01 |
| N0-vs-N1 |
8.884400E-01 |
| N0-vs-N2 |
4.205600E-01 |
| N1-vs-N2 |
4.750000E-01 |
|
|
